Smartleaf Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Smartleaf Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.3K	Hold	211	–	–	﹤0.01%	1492
2026 Q1	$40.7K	Sell	211 -4	-2%	-$827	﹤0.01%	1568
2025 Q4	$45.1K	Buy	215 +105	+95%	+$21K	﹤0.01%	1609
2025 Q3	$19.4K	Buy	110 +30	+38%	+$5.11K	﹤0.01%	1822
2025 Q2	$12.9K	Hold	80	–	–	﹤0.01%	1731
2025 Q1	$13.2K	Hold	80	–	–	﹤0.01%	1814
2024 Q4	$13.2K	Hold	80	–	–	﹤0.01%	1879
2024 Q3	$13.7K	Hold	80	–	–	﹤0.01%	1565
2024 Q2	$12.4K	Hold	80	–	–	﹤0.01%	1297
2024 Q1	$12.4K	Buy	+80	New	+$12.2K	﹤0.01%	965

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Smartleaf Asset Management's FBT Position: Q2 2026 in Review

Smartleaf Asset Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 211 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Smartleaf Asset Management first reported a position in FBT in Q1 2024 and has held it in 10 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Smartleaf Asset Management held 211 shares of First Trust NYSE Arca Biotechnology Index Fund worth $52.3K as of Q2 2026.
Smartleaf Asset Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1492 holding.
Smartleaf Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2024 and has held it in 10 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.